A study on donepezil pharmacokinetics and QT time

A study on donepezil pharmacokinetics and QT time - A study on donepezil pharmacokinetics and QT time

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041362

Enrollment

Registered

2020-08-12

Start date

2019-02-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

Taking donepezil Not taking donepezil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: As of January 1, 2019, outpatients over 65 years of age who had Alzheimer's disease and underwent treatment with donepezil at Tarumizu Chuo Hospital.

Exclusion criteria

Exclusion criteria: Taking anti-arrhythmic medications, a history of cardiac surgery including pacemaker implantation, and renal failure requiring hemodialysis.

Design outcomes

Primary

Measure	Time frame
Relationship between blood concentration of donepezil and QT time.	—

Countries

Japan

Contacts

Public ContactSo Kuwahata

Tarumizu Chuo Hospital, Tarumizu Municipal Medical Center Department of Cardiovascular Medicine

sokuwahata@ybb.ne.jp0994325211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026